大型多中心试验在经费紧张环境下的财务管理
D2d 研究是一项 NIH 资助的大型临床试验,在 2423 名糖尿病高风险参与者中检验维生素 D 补充对糖尿病发病的影响,并开发并应用了混合财务管理模型。该模型将站点预算分为核心经费(约 40%)和基于绩效的支付(约 60%),根据实际招募和访视自动发放。相比传统成本报销模式,混合模型在试验前 4 年节省了经费(65% 对 83%),且未损害科学完整性。
要点
- 混合财务模型将站点预算分为核心经费(约 40%)和绩效支付(约 60%)。
- 绩效支付根据实际招募和访视由协调中心自动发放。
- 该模型可节省公共研究经费且不损害试验科学完整性。
核心结论
- 采用混合财务管理方法审慎分配有限的公共研究资金是可行的,不会损害试验的科学完整性,并能确保资金节约以完成招募和继续随访。
研究设计与样本
- D2d 研究是一项 NIH 支持的大型临床试验,在 2423 名糖尿病高风险参与者中测试维生素 D 补充对糖尿病发病的影响,开发并应用了混合财务管理模型。
主要发现
- 各站点中位招募人数为 88 名参与者(范围 29-318;为站点目标的 20% 至 205%)。
- 第 1 年末,全研究招募达到目标的 12%(预测为 50%),已投入总拨款 award 的 12%。
关键数值与推荐
- 核心经费约占站点总预算的 40%,用于研究启动和部分持续努力,由站点开票。
- 绩效支付约占站点总预算的 60%,用于成功招募参与者和完成随访访视,由协调中心根据实际招募和访视自动发放。
- 表现不佳的站点过渡为仅绩效支付。
临床怎么用
- 在公共研究资金有限的环境下,可考虑采用混合财务管理模型,将部分站点预算与绩效挂钩以激励招募和随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Randomized clinical trials that have public health implications but no or low potential for commercial gain are predominantly funded by governmental (e.g., National Institutes of Health (NIH)) and not-for-profit organizations. Our objective was to develop an alternative clinical trial site funding model for judicious allocation of declining public research funds. METHODS: In the Vitamin D and Type 2 Diabetes (D2d) study, an NIH-supported, large clinical trial testing the effect of vitamin D supplementation on incident diabetes in 2423 participants at high risk for diabetes, a hybrid financial management model for supporting collaborating clinical sites was developed and applied. The funding model employed two reimbursement components: Core (for study start-up and partial efforts throughout the study, ~40% of the total site budget), invoiced by sites, and Performance-Based Payments (for successful enrollment of participants and completion of follow-up visits, ~60% of the total site budget), automatically issued to the sites by the Coordinating Center based on actual recruitment and visits conducted. Underperforming sites transitioned to Performance-Based Payments only. RESULTS: Recruitment occurred from October 2013 through December 2016, requiring one additional year than the 2-year projection. Median enrollment at each site was 88 participants (range 29-318; 20 to 205% of the site target). At the end of year 1, study-wide recruitment was at 12% of the target (vs. 50% projected) and 12% of the total grant award was invested. The model constantly evaluated sites' needs and re-allocated resources to meet the study enrollment goal. If D2d had issued cost reimbursement subaward agreements and sites invoiced for their entire budget, 83% of the award would have been spent for all study activities over the first 4 years of the trial compared to 65% of the award spent (US$26M) under the hybrid model used by D2d. CONCLUSIONS: It is feasible to foster a hybrid financial management approach to steward limited available public funds for research in a dynamic and consistent way that does not compromise the trial's scientific integrity and ensures conservation of funds to complete recruitment and continue to follow up participants.
引用
- Lovegreen O, Riggs D, Staten MA, et al. Financial management of large, multi-center trials in a challenging funding milieu. Trials. 2018. PMID: 29724229. doi:10.1186/s13063-018-2638-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。